Electroacupuncture therapy for improving walking ability in elderly patients with sarcopenia
Efficacy on Walking Ability of Electroacupuncture Therapy in Elderly Patients With Sarcopenia：a Randomized Controlled Trial
This study is testing if adding electroacupuncture to rehabilitation training can help older adults with sarcopenia walk better and improve their muscle strength.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 60 Years to 95 Years |
| Sex | All |
| Sponsor | The Third Affiliated hospital of Zhejiang Chinese Medical University Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Trial ID | NCT05431010 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the efficacy and safety of electroacupuncture therapy combined with rehabilitation training in elderly patients diagnosed with sarcopenia. A total of 120 participants will be randomly assigned to either the electroacupuncture group or a control group receiving only rehabilitation training. The primary focus is on improving lower limb mobility, assessed through various physical performance tests, while secondary outcomes include muscle mass and strength measurements. The study will evaluate outcomes before the intervention, after 12 weeks of treatment, and at a 12-week follow-up.
Who should consider this trial
Good fit: Ideal candidates are elderly individuals aged 60 to 95 who can walk and communicate independently and meet the diagnostic criteria for sarcopenia.
Not a fit: Patients with serious underlying health conditions, severe mental illness, or those unable to participate in rehabilitation training may not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could significantly enhance walking ability and overall mobility in elderly patients suffering from sarcopenia.
How similar studies have performed: While the efficacy of electroacupuncture in treating sarcopenia is still being explored, similar approaches in other studies have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. 60 years ≤ age ≤ 95 years, male or female; 2. Patients are able to walk and communicate independently, and can complete required rehabilitation training; 3. Patients meet the diagnostic criteria proposed by the Asian Working Group for Sarcopenia(AWGS); 4. Patients volunteer to participate in this study and sign the informed consent. Exclusion Criteria: 1. Patients with serious primary diseases of heart, brain, liver, kidney and hematopoietic system; 2. Patients with severe mental illness, cognitive impairment, and disorientation; 3. Patients have trauma and unsuitable for sports; 4. Patients with electronic devices or metal objects implanted in the body; 5. Patients can't complete the required rehabilitation training; 6. Patients cannot receive EA treatment due to any reasons 7. Patients are participating in other drugs, acupuncture and massage trials.
Where this trial is running
Hangzhou, Zhejiang
- The Third Affiliated Hospital of Zhejiang Chinese Medical University — Hangzhou, Zhejiang, China (Recruiting)
Study contacts
- Principal investigator: Ming Guo, Doctor — Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Study coordinator: Wenzhe Wu, Master
- Email: 2008777.1378@163.com
- Phone: 18757570729
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.